Creatine as a Therapeutic Target in Alzheimer's Disease
Open Access
- 29 September 2023
- journal article
- review article
- Published by Elsevier in Current Developments in Nutrition
- Vol. 7 (11) , 102011
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Aging (K01 AG065487, P30 AG072973)
- Alzheimer's Association (AARG-22-924314)
- National Institutes of Health
This publication has 106 references indexed in Scilit:
- Creatine and guanidinoacetate transport at blood‐brain and blood‐cerebrospinal fluid barriersJournal of Inherited Metabolic Disease, 2012
- Skill execution and sleep deprivation: effects of acute caffeine or creatine supplementation - a randomized placebo-controlled trialJournal of the International Society of Sports Nutrition, 2011
- Reduced Lean Mass in Early Alzheimer Disease and Its Association With Brain AtrophyArchives of Neurology, 2010
- Association of Muscle Strength With the Risk of Alzheimer Disease and the Rate of Cognitive Decline in Community-Dwelling Older PersonsArchives of Neurology, 2009
- mTOR signaling at a glanceJournal of Cell Science, 2009
- The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomiesProceedings of the National Academy of Sciences, 2009
- Creatine abnormalities in schizophrenia and bipolar disorderPsychiatry Research: Neuroimaging, 2009
- Cerebral energetic effects of creatine supplementation in humansAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- A “mitochondrial cascade hypothesis” for sporadic Alzheimer's diseaseMedical Hypotheses, 2004
- Direct Antioxidant Properties of CreatineBiochemical and Biophysical Research Communications, 2002